Lab Reagents
Human IgG antibody Laboratories manufactures the test igg / igm sars-cov2 thailand reagents distributed by Genprice. The Test Igg / Igm Sars-Cov2 Thailand reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Test products are available in stock. Specificity: Test Category: Igg Group: / Igm
/ Igm information
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL) |
NATSARS(COV2-SA)-ST |
Zeptometrix |
1 mL |
EUR 933 |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL) |
NATSARS(COV2-UK)-ST |
Zeptometrix |
1 mL |
EUR 933 |
NATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL) |
NATSARS(COV2)-VP |
Zeptometrix |
4 x 0.5mL |
EUR 355 |
SARS Coronavirus IgM ELISA Kit |
DEIA1036 |
Creative Diagnostics |
96T |
EUR 2590.8 |
Description: For the qualitative determination of IgM class antibodies against SARS Coronavirus in Human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by SARS Coronavirus. |
SARS-CoV-2 Rapid Antigen Test Nasal |
9901-NCOV-03G |
Roche Diagnostics |
25 Tests/Kit |
EUR 112.8 |
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
SARS-CoV-2 Antigen Rapid Test Kit |
CoV2Ag-1 |
UnScience |
1T |
EUR 9.6 |
|
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again. |
SARS-CoV-2 Antigen Rapid Test Kit |
CoV2Ag-25 |
UnScience |
25T/kit |
EUR 42 |
|
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection. |
Adv (Adenovirus Antibody IgM) ELISA test |
44 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of Adv (Adenovirus Antibody IgM) |
ACA (Anticardiolipin Antibody IgM) ELISA test |
60 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of ACA (Anticardiolipin Antibody IgM) |
COX (Coxsackievirus Antibody IgM) ELISA test |
141 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of COX (Coxsackievirus Antibody IgM) |
TOX (Toxoplasma Antibody IgM) ELISA test |
33 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of TOX (Toxoplasma Antibody IgM) |
RV (Rubella Antibody IgM) ELISA test |
31 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of RV (Rubella Antibody IgM) |
CMV (Cytomegalovirus Antibody IgM) ELISA test |
29 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CMV (Cytomegalovirus Antibody IgM) |
Mouse phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM |
YLA0711MO-48T |
Shanghai YL Biotech |
48T |
EUR 465 |
Mouse phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM |
YLA0711MO-96T |
Shanghai YL Biotech |
96T |
EUR 600 |
HDV-IgG hepatitis D IgG ELISA test |
88 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of HDV-IgG hepatitis D IgG |